Loading
AP
Ampio Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BUCHI J KEVIN, was filed 13 Jun 2023.
Insider Decl.
64
Thresholds
n/a
Buy Volume
€104,057
14 ops. · all time
Sell Volume
€324,552
8 ops. · all time
Since the insiders bought
- -97.4%Entry US$5.07 · Close at T+365 US$0.13
- -95.7%Entry US$5.80 · Close at T+365 US$0.25
- -94.7%Entry US$5.12 · Close at T+365 US$0.27
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
US$0.18
Analyst consensus
Income statement
EBITDA-US$9.4M
Net income-US$8.6M0.0% margin
Valuation
P/Book0.0x
Beta17.51
Balance sheet & cash
Total debtUS$274k
Free Cash Flow-US$8.6M
Debt / Equity13%
Profitability & ownership
ROE-114.0%
ROA-61.6%
% institutions0.0%
Last declaration on 13 June 2023
Declarations64 total
21,858 shares@ US$0.287522.5% of flowCommon StockSEC:0001615594-23-000047:0
Canonical exit: 7 Sept 2023 (T+90)
25,000 shares@ US$0.29626.4% of flowCommon StockSEC:0001615594-23-000046:0
Canonical exit: 6 Sept 2023 (T+90)
76,890 shares@ US$0.2877100.0% of flowCommon StockSEC:0001615594-23-000035:0
Canonical exit: 22 Aug 2023 (T+90)
32,534 shares@ US$0.274331.6% of flowCommon StockSEC:0001615594-23-000033:0
Canonical exit: 14 Aug 2023 (T+90)
44,026 shares@ US$0.246627.8% of flowCommon StockSEC:0001615594-23-000032:1
Canonical exit: 13 Aug 2023 (T+90)
23,440 shares@ US$0.235219.5% of flowCommon StockSEC:0001615594-23-000032:0
Canonical exit: 10 Aug 2023 (T+90)
25,000 shares@ US$0.2154.7% of flowCommon StockSEC:0001615594-23-000031:1
Canonical exit: 9 Aug 2023 (T+90)
45,000 shares@ US$0.228.6% of flowCommon StockSEC:0001615594-23-000031:2
Canonical exit: 10 Aug 2023 (T+90)
25,000 shares@ US$0.22100.0% of flowCommon StockSEC:0001615594-23-000031:0
Canonical exit: 9 Aug 2023 (T+90)
47,200 shares@ US$0.5728.2% of flowCommon StockSEC:0001415889-22-000258:0
68,400 shares@ US$0.5735.9% of flowCommon StockSEC:0001415889-22-000257:0
22,914 shares@ US$0.5716.1% of flowCommon StockSEC:0001415889-22-000260:0
28,127 shares@ US$1.6455.4% of flowCommon StockSEC:0001415889-21-005020:0
43,470 shares@ US$1.6464.1% of flowCommon StockSEC:0001415889-21-005016:0
41,980 shares@ US$1.6470.5% of flowCommon StockSEC:0001415889-21-005018:0
500,000 shares0Common StockSEC:0001415889-21-004868:0
335,000 shares0Common StockSEC:0001415889-21-004869:0
950,000 shares0Common StockSEC:0001415889-21-004870:0
22,500 shares@ US$1.798.6% of flowCommon StockSEC:0001415889-21-003253:1
22,500 shares@ US$0.4311.3% of flowCommon StockSEC:0001415889-21-003253:0
2,603 shares@ US$2.001.7% of flowCommon StockSEC:0001415889-21-002667:1
6,737 shares@ US$2.006.3% of flowCommon StockSEC:0001415889-21-002666:1
2,603 shares@ US$0.511.3% of flowCommon StockSEC:0001415889-21-002667:0
6,737 shares@ US$0.40100.0% of flowCommon StockSEC:0001415889-21-002666:0
35,000 shares@ US$1.82813.3% of flowCommon StockSEC:0001415889-21-002569:1
25 of 64 declarations
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc.'s insider filings stop in 2023: 64 filings published between January 6, 2016 and June 13, 2023, none in the last twelve months. The file counts 14 purchases, worth EUR 104,057 (median EUR 6,345), and 8 sales, worth EUR 324,552 (median EUR 33,421), so 64% are purchases. Michael A. Martino (CEO) bought EUR 20,564 on May 24, 2023, Philip H. Coelho (Director) EUR 14,069 on September 5, 2017 and J. Kevin Buchi (Director) EUR 9,984 on May 15, 2023. From May 11 to June 9, 2023, 3 insiders bought for EUR 75,543. The 14 purchases tracked to day 90 have a stored median of -18%, positive in 36% of cases (past results as stored, not a forecast).
The sales are all from 2021: Holli Cherevka (CHIEF OPERATING OFFICER) for EUR 123,456 on April 27, Dan Stokely (CFO) for EUR 61,252 on March 16 and EUR 52,340 on May 18.
Read moreShow less
Philip H. Coelho is the top filer, with 17 filings, 5 purchases and 3 sales among them; Dan Stokely has 12, David R. Stevens (Director) 9, with 3 purchases, Holli Cherevka 8 and Richard B. Giles 6. 31 grants and 11 option exercises complete the register of 9 filers. 2021 has 30 filings, against 3 in 2016 and 3 in 2022. Median publication delay: 2 days.
